Literature DB >> 30774321

Feasibility and efficacy of enhanced recovery after surgery protocol in Chinese elderly patients with intracranial aneurysm.

Hui Han1, Songtao Guo1, Hao Jiang1, Xi Wu1.   

Abstract

OBJECTIVE: Intracranial aneurysm is a kind of severe intracranial disease mainly responsible for subarachnoid hemorrhage, and the rupture of intracranial aneurysm results in a mortality rate of 30%-40%. For the first time in the world, this study aimed to assess the feasibility and efficacy of enhanced recovery after surgery (ERAS) protocol in Chinese elderly patients with intracranial aneurysm.
METHODS: In this study, 300 elderly patients with intracranial aneurysm were recruited and divided into two groups as follows: ERAS group (n=150, ERAS protocol) and control group (n=150, conventional management).
RESULTS: Age of whole cohort was 65 (64-67) years with 140 males (46.7). There was no difference between two groups in baseline features of patients, such as age, sex, medical histories, percentages of aneurysmal location, aneurysmal number >1 per patient, aneurysmal diameter >5 mm, or lobular aneurysm (P>0.05 for all). There was no occurrence of death in two groups. Compared with those in the control group, patients in the ERAS group had significantly shorter length of hospital stay (P<0.05). Between two groups, patients had not only similar Glasgow Outcome Scale (GOS) and Modified Rankin Scale (MRS) at discharge but also occurrence of readmission at follow-up (P>0.05 for all). Patients in the ERAS group had significantly higher GOS and lower MRS at follow-up (P<0.05 for all).
CONCLUSION: ERAS protocol significantly shortened the length of hospital stay and improved GOS and MRS without any increase in the mortality or readmission in Chinese elderly patients with intracranial aneurysm.

Entities:  

Keywords:  elderly; enhanced recovery after surgery; intracranial aneurysm

Mesh:

Year:  2019        PMID: 30774321      PMCID: PMC6350647          DOI: 10.2147/CIA.S187967

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


Introduction

Intracranial aneurysm is a kind of severe intracranial disease mainly responsible for subarachnoid hemorrhage, and the rupture of intracranial aneurysm results in a mortality rate of 30%–40%.1,2 Although significant advance has been made in surgical operation of intracranial aneurysm, there is still poor post-operative recovery in patients with intracranial aneurysm.1,3 In addition to those related to disease itself and surgical operation, stress response, persistent pain, and metabolic demand serve as critical pathogenic factors in post-operative recovery.4 Enhanced recovery after surgery (ERAS) offers a series of approaches, such as professional education, nutritional care, improved anesthesia, and fluid management.5 ERAS protocol has been applied for various operations, such as colonic, pancreaticoduodenectomy, cystec-tomy, gastrectomy, and rectal/pelvic operation.6–10 ERAS protocol has the chance to not only accelerate the recovery of different patients but also shorten the length of hospital stay.11 However, there is nearly no study to analyze the feasibility and efficacy of ERAS protocol in Chinese elderly patients with intracranial aneurysm. For the first time in the world, this study aimed to assess the feasibility and efficacy of ERAS protocol in Chinese elderly patients with intracranial aneurysm.

Methods

Study patients

From January 2011 to July 2017, 300 patients at the Department of Neurosurgery, Inner Mongolia Xing’an Meng People’s Hospital were recruited in this study. The inclusion criteria include the following: 1) age over 60 years; 2) medical history, clinical appearance (dizziness, headache, and nerve localization signs), and diagnostic imaging (computed tomography angiography [CTA] or digital subtraction angiography [DSA]) supported the diagnosis of intracranial aneurysm; 3) surgical treatment of intracranial aneurysm; and 4) the ability to understand and participate in this study. The exclusion criteria include the following: 1) contraindications to surgical treatment of intracranial aneurysm and 2) severe cardiac, hepatic, renal, and other systematic diseases. The study protocol has been approved by the ethics committee of Inner Mongolia Xing’an Meng People’s Hospital, and it conforms to the Declaration of Helsinki. Each participant provided written informed consent to be included in the study.

Study protocol

Patients were randomly allocated to two groups as follows: ERAS group (n=150, ERAS protocol) and control group (n=150, conventional management). Surgical treatment of intracranial aneurysm was performed by united team with full experience. Patients were placed in the supine position, and operation was performed under general anesthesia. Minimally invasive surgical approach through small pterion or inferolateral forehead was applied in all patients. Intra-cranial aneurysm was treated with clipping. Operation was monitored by electroencephalogram and somatosensory evoked potential. Blood flow and its patency were assessed during the operation by microvascular Doppler ultrasound. Fluorescence angiography was applied to assess the patency of parental artery and perforating artery.

ERAS protocol

ERAS protocol was performed as shown in Table 1.12 In addition to educating the patient on surgical risks and benefits as part of the control protocol, pre-operative education of the ERAS protocol included the information about appointments and instructions, testing and drugs, eating and drinking, smoking and alcohol, expectations about disposition, and surgical site care.4 In addition to post-operative instrument of the control protocol at clinics after discharge based on the self-determination of patients, patients received phone reminder from surgical doctors within 48 hours of discharge and every week after operation to assess pain management, identify patient concerns, and clarify follow-up instrument.
Table 1

ERAS strategy performed in this study

StrategyControl groupERAS group
Preoperative
Preoperative educationConventionalDetailed (ERAS strategy)
Oral dietNothing for 8 hours before operationFluids until 2 hours and solids until 6 hours before operation
Short-acting anxiolyticsOccasionallyConventional
Corticosteroid and antiemeticOccasionallyConventional
Operative
Patient-controlled analgesia pumpNoYes
Nasogastric tubeConventionalMinimized
Room temperatureConventional>25°C
Heated liquidNoYes
Warm airNoYes
Fluid administrationConventionalGoal-directed manner
Postoperative
Urinary catheter removalThree days after operationOne day after operation
WaterTwelve hours after operationSix hours after operation
Liquid foodTwo days after operationOne day after operation
Semiliquid dietThree or four days after operationTwo days after operation
Normal dietFive or six days after operationThree days after operation
Fluid administrationConventionalRestricted (<2,500 mL)
Patient-controlled analgesia pumpNoYes
Pulmonary physical therapyNoConventional
Instrument after dischargeSelf-determination of patientsPhone reminder, detailed and frequent

Abbreviation: ERAS, enhanced recovery after surgery.

Outcome measure

All patients were followed up for 1 year, and there were no patients lost during the follow-up. The primary outcomes were assessed by the mortality and the length of hospital stay after operation (the number of days from operation to discharge) during the first year after operation. The secondary outcome was assessed by the readmission during the first year after operation. Glasgow Outcome Scale (GOS) and Modified Rankin Scale (MRS) were applied to assess neurological function and prognostic performance at discharge and the first year after operation.

Statistical analyses

Continuous variables with normal distribution were described using mean and SD and compared between two groups using Student’s t-test. Continuous variables with skewed distribution were described using median and IQR and compared between two groups using the Mann–Whitney U test. Categorical variables were described with number and percentage and compared between two groups using the chi-squared test. Statistical analysis was performed using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA). P<0.05 was considered to be statistically significant.

Results

Age of whole cohort was 65 (64–67) years with 140 males (46.7%). As shown in Table 2, there was no difference between two groups in baseline features of patients, such as age, sex, medical histories, percentages of aneurysmal location, aneurysmal number >1 per patient, aneurysmal diameter >5 mm, or lobular aneurysm (P>0.05 for all). Clinical outcomes of patients were compared between two groups in Table 3. There was no occurrence of death in two groups. Compared with those in the control group, patients in the ERAS group had significantly shorter length of hospital stay (P<0.05). Between two groups, patients had not only similar GOS and MRS at discharge but also occurrence of readmission at follow-up (P>0.05 for all). Patients in the ERAS group had significantly higher GOS and lower MRS at follow-up (P<0.05 for all).
Table 2

Baseline features of all patients divided into ERAS and control groups

FeaturesAll patients (n=300)Control group (n=150)ERAS group (n=150)P-value
Age, years65 (64–67)65 (64–67)65 (64–68)0.451
Males, n (%)140 (46.7)69 (46.0)71 (47.3)0.817
Hypertension, n (%)158 (52.7)77 (51.3)81 (54.0)0.644
Diabetes mellitus, n (%)85 (28.3)39 (26.0)46 (30.7)0.370
Aneurysmal location, n (%)0.705
Posterior communicating and anterior choroidal aneurysm151 (50.3)79 (52.7)72 (48.0)
Middle cerebral aneurysm70 (23.3)34 (22.7)36 (24.0)
Anterior communicating aneurysm79 (26.3)37 (24.7)42 (28.0)
Aneurysmal number >1 per patient, n (%)21 (7.0)10 (6.7)11 (7.3)0.821
Aneurysmal diameter >5 mm, n (%)63 (21.0)29 (19.3)34 (22.7)0.478
Lobular aneurysm, n (%)84 (28.0)38 (25.3)46 (30.7)0.304

Abbreviation: ERAS, enhanced recovery after surgery.

Table 3

Clinical outcomes of all patients divided into ERAS and control groups

OutcomesControl group (n=150)ERAS group (n=150)P-value
Length of hospital stay, days10 (8–12)9 (7–11)0.019
Readmission, n (%)4 (2.7)2 (1.3)0.680
GOS at discharge, n (%)
5143 (95.3)147 (98.0)0.198
47 (4.7)3 (2.0)
MRS at discharge, n (%)
0–1134 (89.3)143 (95.3)0.148
29 (6.0)4 (2.7)
37 (4.7)3 (2.0)
GOS at follow-up, n (%)
5138 (92.0)146 (97.3)0.040
412 (8.0)4 (2.7)
MRS at follow-up, n (%)
0–1126 (84.0)140 (93.3)0.034
212 (8.0)6 (4.0)
312 (8.0)4 (2.7)

Abbreviations: ERAS, enhanced recovery after surgery; GOS, Glasgow Outcome Scale; MRS, Modified Rankin Scale.

Discussion

Intracranial aneurysm is a kind of severe intracranial disease mainly responsible for subarachnoid hemorrhage, and the rupture of intracranial aneurysm results in a mortality rate of 30%–40%.1,2 Although significant advance has been made in surgical operation of intracranial aneurysm, there is still poor post-operative recovery in patients with intracranial aneurysm.1,3 Surgical treatment of intracranial aneurysm often requires complex operation, as well as careful preoperative preparation, intraoperative care, and post-operative management.12 Enhanced recovery is significant in patients with intracranial aneurysm but evidence-based protocol on perioperative care for this population is lacking. For the first time in the world, this study confirmed that the ERAS protocol significantly shortened the length of hospital stay and improved GOS and MRS without any increase in the mortality or readmission in Chinese elderly patients with intracranial aneurysm. Stress response, persistent pain, and metabolic demand related to surgical operation delay the recovery of patients after operation.4 ERAS protocol has been introduced as a way of optimizing perioperative care for different operations, such as colonic, pancreaticoduodenectomy, cystectomy, gastrectomy, and rectal/pelvic operation.6–10 Improving perioperative care in an evidence-based and structured manner is the primary goal of the ERAS protocol. Evaluation of the ERAS protocol in patients with these diseases has shown that these patients had shorter length of hospital stay and experienced significant improvements in recovery after operation.12 ERAS protocol has revolutionized the way of perioperative care in surgical field. However, no evidence has been offered to support the ERAS protocol in Chinese elderly patients with intracranial aneurysm. In this study, the ERAS protocol offers a series of approaches, such as professional education, nutritional care, improved anesthesia, and fluid management.5 It is no surprise for these approaches to alleviate stress response, persistent pain, and metabolic demand related to surgical operation and promote the recovery of patients with intracranial aneurysm after operation.12

Conclusion

For the first time in the world, this study demonstrated that the ERAS protocol significantly shortened the length of hospital stay and improved GOS and MRS without any increase in the mortality or readmission in Chinese elderly patients with intracranial aneurysm.
  12 in total

Review 1.  Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations.

Authors:  Yannick Cerantola; Massimo Valerio; Beata Persson; Patrice Jichlinski; Olle Ljungqvist; Martin Hubner; Wassim Kassouf; Stig Muller; Gabriele Baldini; Francesco Carli; Torvind Naesheimh; Lars Ytrebo; Arthur Revhaug; Kristoffer Lassen; Tore Knutsen; Erling Aarsether; Peter Wiklund; Hitendra R H Patel
Journal:  Clin Nutr       Date:  2013-10-17       Impact factor: 7.324

Review 2.  Optimal Perioperative Care in Major Head and Neck Cancer Surgery With Free Flap Reconstruction: A Consensus Review and Recommendations From the Enhanced Recovery After Surgery Society.

Authors:  Joseph C Dort; D Gregory Farwell; Merran Findlay; Gerhard F Huber; Paul Kerr; Melissa A Shea-Budgell; Christian Simon; Jeffrey Uppington; David Zygun; Olle Ljungqvist; Jeffrey Harris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-03-01       Impact factor: 6.223

3.  Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  Kristoffer Lassen; Marielle M E Coolsen; Karem Slim; Francesco Carli; José E de Aguilar-Nascimento; Markus Schäfer; Rowan W Parks; Kenneth C H Fearon; Dileep N Lobo; Nicolas Demartines; Marco Braga; Olle Ljungqvist; Cornelis H C Dejong
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

4.  Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations.

Authors:  U O Gustafsson; M J Scott; W Schwenk; N Demartines; D Roulin; N Francis; C E McNaught; J Macfie; A S Liberman; M Soop; A Hill; R H Kennedy; D N Lobo; K Fearon; O Ljungqvist
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

5.  Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations.

Authors:  J Nygren; J Thacker; F Carli; K C H Fearon; S Norderval; D N Lobo; O Ljungqvist; M Soop; J Ramirez
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

6.  Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  K Mortensen; M Nilsson; K Slim; M Schäfer; C Mariette; M Braga; F Carli; N Demartines; S M Griffin; K Lassen
Journal:  Br J Surg       Date:  2014-07-21       Impact factor: 6.939

7.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

8.  Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment.

Authors:  David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

Review 9.  Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.

Authors:  Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2013-11-27       Impact factor: 44.182

10.  Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial.

Authors:  Jong Won Kim; Whan Sik Kim; Jae-Ho Cheong; Woo Jin Hyung; Seung-Ho Choi; Sung Hoon Noh
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

View more
  3 in total

1.  Expression of serum miR-126 in patients with intracranial aneurysm and its relationship with postoperative cerebral vasospasm.

Authors:  Jing Luo; Xiaoqun Zhu; Fei Liu; Liang Zhao; Zhenghao Sun; Yan Li; Lei Ye; Weizu Li
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Long Non-coding RNA MALAT1/microRNA-143/VEGFA Signal Axis Modulates Vascular Endothelial Injury-Induced Intracranial Aneurysm.

Authors:  Ge Gao; Yang Zhang; Jian Yu; Yu Chen; Daqun Gu; Chaoshi Niu; Xianming Fu; Jianjun Wei
Journal:  Nanoscale Res Lett       Date:  2020-06-29       Impact factor: 4.703

Review 3.  Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus.

Authors:  Ying Wang; He Han; Said Abdulrahman Salim Mzee; Deqian Wang; Jixiang Chen; Xin Fan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.